ALC Alcon Inc. Ordinary Shares

XNYS 74.97 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

ALC $74.97 —

What changed

Recent filings, trades and moves
Key stats
$74.97
52-Week Range
$61.84 – $87.64
YTD
-3.38%
IV Rank (30D)
84.08
Straddle Price
$6.90
P/C Vol Ratio
0.94
Market Cap
$36.2B
Open
$74.62
Day Range
$74.28 – $75.19
Volume
1,768,265
Prev Close
$74.94
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.90%
Beta vs SPY0.88
Cost of Equity (CAPM)9.29% (VRP-adj)
WACC9.03%
Volatility Risk Premium+16.9pp (IV − HV30)
Effective Tax Rate10.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.6B
Return on Equity (TTM)2.2%
Book / Price59.3% — banking bias active (P/B is primary)
Debt / Equity0.19
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$67.83 (Market Anchor value)
SMA 20 / Bollinger Mid$69.64
Bollinger Width / SMA2022.7% (drives anchor stability)
Net Debt$2.6B
Market Cap$37B
Peers used for multiples: ICE, ROP, SCHW (filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
38%
20-Day Fair Value
≈ by Dec 8, 2026
$75.51
α +0.5% rank 72%
conviction
36%
40-Day Fair Value
≈ by Jan 6, 2027
$75.89
α +1.0% rank 72%
conviction
37%
60-Day Fair Value
≈ by Feb 4, 2027
$74.13
α -1.4% rank 72%
conviction
38%
MethodImplied PriceWeightDetail
DCF $13.99 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 18.8× · 3 peers
Peer EV/EBITDA n/a 0% median 16.2× · 3 peers
Peer P/B $141.66 18% median 3.2× · 3 peers
Peer P/S n/a 0% median 5.8× · 3 peers
Market Anchor (SMA50) $67.83 34% stability 37% (BB-width)
Options Expected (B-L 30d) $75.02 47% 22 strikes · skew +0.04
As of 2026-11-09 · updated
About
Industry (SIC)
OPHTHALMIC GOODS (3851) · industry map
Exchange
XNYS
Market Cap
$36.2B
Employees
25,942
List Date
2019-04-09
CIK
0001167379
Next Earnings
2026-11-10 (After-Close)
EPS Forecast
$0.89
Homepage
https://www.alcon.com

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Month'21'22'23'24'25'26Avg
Jan9.18%-11.88%9.03%-2.51%9.16%4.36%2.89%
Feb-6.10%-1.52%-10.70%10.68%2.32%9.83%0.75%
Mar-0.37%4.23%3.80%-3.98%0.84%-11.02%-1.08%
Apr6.00%-10.70%4.42%-5.41%5.30%-0.85%-0.21%
May-8.27%5.48%7.49%13.50%-10.64%-10.53%-0.49%
Jun-0.07%-5.86%4.44%-0.62%3.65%2.13%0.61%
Jul3.45%9.09%4.79%6.73%-1.65%3.61%4.34%
Aug11.78%-15.87%-0.80%4.11%-9.17%2.63%-1.22%
Sep-3.25%-12.43%-6.61%4.57%-4.80%-9.76%-5.38%
Oct3.82%2.15%-5.45%-7.23%-1.62%11.75%0.57%
Nov-7.11%13.92%4.58%-3.20%7.35%2.04%*2.93%
Dec11.18%-2.17%2.99%-3.79%0.78%--1.80%
Total19.05%-26.61%17.13%10.97%-0.57%1.10%3.51%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $70.18
SMA 50: $67.89
SMA 200: $71.79
Current: $75.06
EMA 12: $72.89
EMA 26: $70.45
MACD: 2.4341 | Signal: 0.6655
BULLISH
ADX (14): 36.39
TREND
+DI: 39.87
−DI: 17.29

Momentum Oscillators

RSI (14): 65.92
NEUTRAL
Stoch %K: 78.87
Stoch %D: 84.45
Williams %R: -25.88

Volume & Volatility

BB Upper: $78.02
BB Lower: $62.33
NEUTRAL
OBV: -47,625,394
Vol SMA 20: 1,904,523
Vol ROC: 19.66%
ATR: $1.70
True Range: $0.91
HV 20: 37.6%
HV 30: 32.5%
HV 60: 27.7%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 7/10)

Key drivers: Strong technical signals, low volatility, and positive news sentiment.

Primary risks: Regulatory challenges, high implied volatility, and potential consolidation.

2-3 sentence investment thesis: ALC is a solid buy opportunity due to its stable price action, improving fundamentals, and reasonable valuation. The stock's beta indicates it moves less than the market, making it an attractive choice for investors seeking reduced risk.

Recent news sentiment impact: Positive headlines from ophthalmology devices market report and 2026 DallasCISO ORBIE Awards recognition have contributed to the bullish bias.

Technical Analysis

Trend Direction: Short-term (1-4 weeks): Uptrend, Medium-term (1-3 months): Sideways range, Long-term (3-12 months): Uptrend

Support/Resistance Levels:

  • Lower band: $65.56
  • Middle band: $68.03
  • Upper band: $70.49
  • Critical price levels to monitor:
    • Support at $67.85 (EMA 26)
    • Resistance at $69.95 (SMA 20)

Momentum Signals:

  • RSI interpretation: Neutral (50.27), no clear buy or sell signal
  • MACD signal: Bullish momentum, crossover above the signal line
  • Bollinger Bands position: Squeeze, indicating potential breakout

Volume Analysis: Volume trends and institutional interest signals are mixed, with a slight increase in volume on recent buying pressure.

News & Sentiment Analysis

Recent Headlines Summary: Positive news about ophthalmology devices market report and recognition from 2026 DallasCISO ORBIE Awards have contributed to the bullish bias. Neutral headlines about Abbott Labs vs. Glaukos and LENSAR stock's update on pending acquisition by Alcon did not significantly impact the analysis.

Sentiment Assessment: Positive sentiment dominates, with only one neutral headline.

Catalyst Identification: Upcoming earnings release could provide a significant catalyst for price movement.

Market Narrative: The market narrative is mixed, with some positive headlines from ophthalmology devices market report and recognition from 2026 DallasCISO ORBIE Awards, while others, such as the LENSAR stock update, are neutral.

Risk & Volatility Assessment

Beta Interpretation: Beta of 0.54 indicates ALC moves less than the market, making it a relatively low-risk investment.

Volatility Regime: Low volatility regime, with historical volatility levels lower than current implied volatility.

Options Market Signals: IV rank is medium (25.2%), indicating historically average volatility. Current IV is high (48.7%), but expected move is relatively contained at $5.35. Unusual activity in options market could indicate institutional interest.

Downside Protection: Support levels and risk management considerations are crucial, as the stock's recent price action has been characterized by low volatility.

Market Context & Positioning

Sector Performance: Relative strength vs sector/market: ALC is performing similarly to its peers.

Institutional Activity: Mixed volume trends and institutional interest signals suggest some buying pressure.

Correlation Analysis: Correlation with SPY is relatively low (0.23), indicating the stock's independence from market movements.

Relative Valuation: Position within trading range: The stock appears reasonably valued, considering its technical and fundamental factors.

Key Levels & Action Items

  • Critical Price Levels: Support at $67.85 (EMA 26) and resistance at $69.95 (SMA 20)
  • Breakout/Breakdown Levels: Technical levels that could trigger significant moves are the upper and lower Bollinger Bands ($70.49 and $65.56, respectively)
  • Time-Sensitive Catalysts: Upcoming earnings release could provide a significant catalyst for price movement
  • Risk Management: Stop-loss levels should be set at $66.50 (SMA 20) to manage potential downside risk

Note: This analysis is based on the provided data and does not constitute investment advice.

Generated

ALC Options Activity & IV Rank

ALC IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 37.7%
7-DTE IV: 51.8%
Expected Move: $6.90
7-DTE Move: $5.40
Days to Exp: 39 (2026-12-18)

Options Flow · All expiries

Call Volume: 2,509
Put Volume: 2,348
P/C Volume: 0.936
NEUTRAL
Call OI: 20,968
Put OI: 22,100
P/C OI: 1.054
Total OI: 43,068

ATM Options Pricing

ATM Call: $3.60
ATM Put: $3.30
Call %: 4.8%
Put %: 4.4%

Chain Summary

Chain Volume: 4,857
Chain OI: 43,068
Last Updated: 11/9/2026
Spread Scanner

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 82nd percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
82%
vs own history
GEX tilt
+0.32
OI-weighted, today
Vanna tilt
-0.09
δ-sensitivity to IV
Charm tilt
+0.37
δ-decay vs time
Charm tilt +0.37: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 62 ATM contracts, 18k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
No data
30 DTE / 10d —
— pts EXTREME
No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)88.1HighNov 9
IV Rank (30 DTE)84.1HighNov 9
Straddle Price (30 DTE)$6.90Nov 9
Beta Analysis

Risk Metrics

Beta: 0.3960
Alpha: 0.92%
Correlation: 0.1863
R-Squared: 3.5%
Stock Volatility: 29.2%
Market Volatility: 13.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own ALC
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$26.5M
0.02%
#996 of 6285-57.4%13F
Rockefeller Capital Management Family office
Rockefeller family
$2.7M
0.00%
#1238 of 4729-6.8%13F
Millennium Management Hedge fund
Izzy Englander
$1.2M
0.00%
#2817 of 3716-82.5%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

ALC Institutional Ownership (13F)

Filings for 2026-06-30 · 289 already for 2026-09-30
Diluted shares outstanding: 493,675,000 (as of 2022-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

641 filers234,762,883 shares$15.61B value47.55% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Capital Management LLC 14,749,582 $994.56M 6.37% 2.99% 2026-06-30
2 Norges Bank 10,976,697 $741.43M 4.75% 2.22% 2026-06-30
3 Invesco Ltd. Custodian 10,380,332 $696.52M 4.46% 2.10% 2026-06-30
4 Bank of New York Mellon Corp Custodian 10,136,925 $656.37M 4.21% 2.05% 2026-09-30
5 AKO CAPITAL LLP 9,683,004 $651.94M 4.18% 1.96% 2026-06-30
6 Aristotle Capital Management, LLC 9,154,828 $614.30M 3.94% 1.85% 2026-06-30
7 Zurcher Kantonalbank (Zurich Cantonalbank) 7,915,741 $535.80M 3.43% 1.60% 2026-06-30
8 FMR LLC Custodian 7,662,988 $514.22M 3.29% 1.55% 2026-06-30
9 UBS Group AG Custodian 7,156,307 $480.19M 3.08% 1.45% 2026-06-30
10 Amundi Custodian 6,514,156 $421.79M 2.70% 1.32% 2026-09-30
11 Select Equity Group, L.P. 5,766,342 $390.26M 2.50% 1.17% 2026-06-30
12 Pictet Asset Management Holding SA 5,489,618 $354.91M 2.27% 1.11% 2026-09-30
13 Goldman Sachs Group Inc Custodian 4,677,162 $313.84M 2.01% 0.95% 2026-06-30
14 Vontobel Holding Ltd. 4,828,384 $311.91M 2.00% 0.98% 2026-09-30
15 Deutsche Bank AG Custodian 4,496,642 $291.16M 1.87% 0.91% 2026-09-30
16 Vanguard Fiduciary Trust Co 4,315,146 $290.97M 1.86% 0.87% 2026-06-30
17 Royal Bank of Canada Custodian 4,016,341 $269.50M 1.73% 0.81% 2026-06-30
18 Allspring Global Investments Holdings, LLC 4,108,434 $262.69M 1.68% 0.83% 2026-09-30
19 Legal & General Group Plc Custodian 3,812,475 $258.06M 1.65% 0.77% 2026-06-30
20 WGI DM, LLC 3,463,123 $232.38M 1.49% 0.70% 2026-06-30
21 Southpoint Capital Advisors LP 3,400,000 $228.14M 1.46% 0.69% 2026-06-30
22 Bank of America Corp Custodian 2,464,811 $165.39M 1.06% 0.50% 2026-06-30
23 Arrowstreet Capital, Limited Partnership 2,388,071 $160.74M 1.03% 0.48% 2026-06-30
24 CAISSE DES DEPOTS ET CONSIGNATIONS 2,374,092 $160.69M 1.03% 0.48% 2026-06-30
25 Barclays PLC Custodian 2,437,768 $157.85M 1.01% 0.49% 2026-09-30
16 filers$427.64M notional
# Filer Notional Value % of Total Period
1 UBS Group AG Custodian $338.05M 79.05% 2026-06-30
2 SIH Partners, LLLP $35.44M 8.29% 2026-06-30
3 Goldman Sachs Group Inc Custodian $10.06M 2.35% 2026-06-30
4 Vontobel Holding Ltd. $9.56M 2.24% 2026-09-30
5 Susquehanna International Group, LLP Custodian $7.86M 1.84% 2026-06-30
6 Millennium Management LLC Custodian $7.08M 1.66% 2026-06-30
7 TUDOR INVESTMENT CORP ET AL $4.52M 1.06% 2026-06-30
8 Twin Tree Management, LP $4.05M 0.95% 2026-06-30
9 Jain Global LLC $3.35M 0.78% 2026-06-30
10 Citadel Advisors LLC Custodian $2.05M 0.48% 2026-06-30
11 Walleye Trading LLC $1.36M 0.32% 2026-06-30
12 CAPITAL FUND MANAGEMENT S.A. $1.29M 0.30% 2026-06-30
13 Walleye Capital LLC $1.29M 0.30% 2026-06-30
14 Point72 Asset Management, L.P. $925.98K 0.22% 2026-06-30
15 Jane Street Group, LLC Custodian $717.97K 0.17% 2026-06-30
16 Quadcap Wealth Management, LLC $26.99K <0.01% 2026-09-30
19 filers$568.89M notional
# Filer Notional Value % of Total Period
1 SIH Partners, LLLP $401.95M 70.65% 2026-06-30
2 Goldman Sachs Group Inc Custodian $51.83M 9.11% 2026-06-30
3 Qube Research & Technologies Ltd $29.84M 5.25% 2026-06-30
4 Millennium Management LLC Custodian $13.83M 2.43% 2026-06-30
5 Susquehanna International Group, LLP Custodian $13.71M 2.41% 2026-06-30
6 UBS Group AG Custodian $13.42M 2.36% 2026-06-30
7 Citadel Advisors LLC Custodian $13.10M 2.30% 2026-06-30
8 Citigroup Inc. Custodian $10.34M 1.82% 2026-09-30
9 Twin Tree Management, LP $7.70M 1.35% 2026-06-30
10 Jain Global LLC $3.35M 0.59% 2026-06-30
11 Jane Street Group, LLC Custodian $3.12M 0.55% 2026-06-30
12 Walleye Capital LLC $1.75M 0.31% 2026-06-30
13 CREDIT INDUSTRIEL ET COMMERCIAL $1.69M 0.30% 2026-06-30
14 Point72 Asset Management, L.P. $1.36M 0.24% 2026-06-30
15 CAPITAL FUND MANAGEMENT S.A. $1.16M 0.20% 2026-06-30
16 CenterStar Asset Management, LLC $394.98K 0.07% 2026-09-30
17 TUDOR INVESTMENT CORP ET AL $301.95K 0.05% 2026-06-30
18 Vontobel Holding Ltd. $25.84K <0.01% 2026-09-30
19 Walleye Trading LLC $13.42K <0.01% 2026-06-30

ALC Insider Trading (Form 4)

Latest: 2013-07-11
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2013-07-11 Kowalczyk Mary Zak Vice President Disp (D) −1,334 $12.00 -$16.0K EDGAR
2013-07-11 Michael J Spector Director Disp (D) −1,200 $12.00 -$14.4K EDGAR
2013-07-11 Derek Buntain Director Disp (D) −46,440 $12.00 -$557.4K EDGAR
2013-07-11 Mel Rhinelander Director Disp (D) −4,860 $12.00 -$58.3K EDGAR
2013-07-11 John Buono Chief Financial Officer Disp (D) −8,000 $12.00 -$96.0K EDGAR
2013-07-11 Malen Ng Director Disp (D) −1,394 $12.00 -$16.7K EDGAR
2013-07-11 Kowalczyk Mary Zak Vice President Disp (D) −1,334 $12.00 -$16.0K EDGAR
2013-07-11 Alan Bell Director Disp (D) −2,000 $12.00 -$24.0K EDGAR
2013-07-11 Walter Alan Levonowich VP & Controller Disp (D) −800 $12.00 -$9.6K EDGAR
2013-07-11 David Hennigar Director Disp (D) −6,622 $12.00 -$79.5K EDGAR
2013-07-11 Chip Roadman Chief Executive Officer Disp (D) −1,200 $12.00 -$14.4K EDGAR
2012-03-19 John Buono Chief Financial Officer Grant (A) +4,400 opt — EDGAR
2012-03-19 Laurie Ann Bebo President & CEO Grant (A) +8,800 opt — EDGAR
2012-03-19 John Buono Chief Financial Officer Grant (A) +4,400 opt — EDGAR
2012-03-19 Kowalczyk Mary Zak Vice President Grant (A) +2,200 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

ALC Proposed Insider Sales (Form 144)

Latest: 2026-02-26
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-02-26 Duplan Sergio Officer 15,000 $1.30M 2026-02-26 Fidelity Brokerage Services LLC — EDGAR
2026-02-26 Attias Laurent Officer 2,412 $209.6K 2026-02-26 Fidelity Brokerage Services LLC — EDGAR
2025-03-03 Duplan Sergio Officer 12,600 $1.17M 2025-03-03 Fidelity Brokerage Services LLC — EDGAR
2025-02-28 STONESIFER TIMOTHY C. Officer 20,000 $1.84M 2025-02-28 Fidelity Brokerage Services LLC — EDGAR
2025-02-27 Attias Laurent Officer 9,000 $826.9K 2025-02-27 Fidelity Brokerage Services LLC — EDGAR
2024-09-12 Endicott David J. Officer, Director 112,182 $11.27M 2024-09-12 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2024-09-12 Bell Ian Officer 10,000 $1.00M 2024-09-12 RBC CAPITAL MARKETS LLC 10b5-1 EDGAR
2024-09-09 Narayanan Rajkumar Officer 4,622 $446.2K 2024-09-09 Fidelity Brokerage Services LLC — EDGAR
2024-08-22 Duplan Sergio Officer 2,000 $191.8K 2024-08-22 Fidelity Brokerage Services LLC — EDGAR
2024-06-04 Narayanan Rajkumar Officer 5,000 $449.0K 2024-06-04 Fidelity Brokerage Services LLC — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
54 ETFs hold ALC
25 shown · $1.90B total exposure · 0.15% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VXUS Vanguard Total International Stock ETF Vanguard 0.07% $460.6M — 2026-09-30
2 VEA Vanguard FTSE Developed Markets ETF Vanguard 0.10% $304.0M — 2026-09-30
3 IEFA iShares Core MSCI EAFE ETF iShares (BlackRock) 0.15% $280.6M $187.1B 2026-11-06
4 EFA iShares MSCI EAFE ETF iShares (BlackRock) 0.18% $132.7M $75.5B 2026-11-06
5 VGK Vanguard FTSE Europe ETF Vanguard 0.20% $75.1M — 2026-09-30
6 VEU Vanguard FTSE All-World Ex-US ETF Vanguard 0.08% $74.2M — 2026-09-30
7 EFV iShares MSCI EAFE Value ETF iShares (BlackRock) 0.22% $66.5M $30.3B 2026-11-06
8 EWL iShares MSCI Switzerland ETF iShares (BlackRock) 2.06% $63.7M $3.1B 2026-11-06
9 IXUS iShares Core MSCI Total International Stock ETF iShares (BlackRock) 0.09% $51.2M $56.4B 2026-11-06
10 SPDW State Street® SPDR® Portfolio Developed World ex-US ETF SPDR (State Street) 0.12% $48.5M $41.0B 2026-11-05
11 ESGD iShares ESG Aware MSCI EAFE ETF iShares (BlackRock) 0.39% $44.9M $11.6B 2026-11-06
12 IDEV iShares Core MSCI International Developed Markets ETF iShares (BlackRock) 0.13% $43.1M $33.4B 2026-11-06
13 EQTY KOVITZ CORE EQUITY ETF Nport 2.98% $42.5M — 2026-07-31
14 DFIV Dimensional International Value ETF Dimensional 0.17% $37.6M $22.0B 2026-11-05
15 VT Vanguard Total World Stock ETF Vanguard 0.03% $27.5M — 2026-09-30
16 IEUR iShares Core MSCI Europe ETF iShares (BlackRock) 0.24% $22.9M $9.6B 2026-11-06
17 DFAI Dimensional International Core Equity Market ETF Dimensional 0.12% $21.1M $17.9B 2026-11-05
18 IXJ iShares Global Healthcare ETF iShares (BlackRock) 0.42% $19.5M $4.6B 2026-11-06
19 EFG iShares MSCI EAFE Growth ETF iShares (BlackRock) 0.13% $18.9M $14.8B 2026-11-06
20 ACWX iShares MSCI ACWI ex U.S. ETF iShares (BlackRock) 0.11% $18.7M $17.5B 2026-11-06
21 DFIC Dimensional International Core Equity 2 ETF Dimensional 0.10% $15.3M $15.1B 2026-11-05
22 ACWI iShares MSCI ACWI ETF iShares (BlackRock) 0.04% $11.8M $31.5B 2026-11-06
23 DFAX Dimensional World ex US Core Equity 2 ETF Dimensional 0.07% $8.6M $11.7B 2026-11-05
24 VSGX Vanguard ESG International Stock ETF Vanguard 0.12% $7.8M — 2026-11-05
25 RUNN Running Oak Efficient Growth ETF Nport 1.84% $7.6M — 2026-08-31
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
—
TTM Revenue
—
TTM Net Income
—
TTM Op. Cash Flow
—
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q4 '252025-12-31————
Q4 '242024-12-31————
Q4 '232023-12-31————
Q4 '222022-12-31————
Q2 '222022-06-30$2.22B$148.00M$0.30—
Q4 '212021-12-31$2.15B$139.00M$0.28$387.00M
Q3 '212021-09-30$2.10B$2.00M—$416.00M
Q2 '212021-06-30$2.11B$151.00M$0.31$386.00M
Q1 '212021-03-31$1.93B$84.00M$0.17$156.00M
Q4 '202020-12-31$1.94B$95.00M$0.19$439.00M
Q3 '202020-09-30$1.84B$-147.00M$-0.30$326.00M
Q2 '202020-06-30$1.21B$-422.00M$-0.86$28.00M
Q4 2025 • period ending 2025-12-31 • filed 2026-02-24
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
84.42
P/B
1.90
P/S
4.32
EV/EBITDA
37.54
EV/Sales
4.66
ROE
2.3%
ROA
1.6%
Div Yield
0.00%
FCF Yield
3.21%
Debt/Equity
0.20
Current Ratio
—
Market Cap
$37.09B
as of 2026-11-09

ALC vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
LLY Eli Lilly & Co. $1.21T 45.9 +45.5% +31.0% 27
V VISA Inc. $788.6B 35.1 +14.8% +22.2% 39
PM Philip Morris International Inc. $308.4B 28.4 +7.9% +21.2% 13
SCHW The Charles Schwab Corporation $158.2B 20.0 +6.4% −8.5% 45
ICE Intercontinental Exchange Inc. $96.3B 23.8 +12.7% +8.9% 13
ROP Roper Technologies, Inc. Common Stock $47.2B 18.6 +9.2% +8.4% 43
ALC Alcon Inc. Ordinary Shares $36.2B — — −3.3% 84
NOVN NOVN — — — −94.3% —
NESN NESN — — — — —
Peer median $233.3B 26.1 +10.9% +8.9% 33

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
19.55M
SI % of Float
4.05%
Days to Cover
10.86
Short Vol Ratio
38.5%
Free Float
—
Float %
—
Short interest 2026-10-15 • Short volume 2026-11-06